Prior works have well established that biomarkers including NT-proBNP [12,13], cTNI [12,14], eGFR [15,16], D-dimer [12,17], and LDL-C [18] have a positive predictive value for stroke and systemic embolism in patients with NVAF. This evidence concerns the gene NPPB and stroke disorder.